There’s no end to new information about vitamin D, skin cancer, and sun protection factor (SPF) levels in sunscreen. Sun-related topics take on special importance for people with lupus. Here are five ...

The New England Journal of Medicine has published a detailed analysis of Genentech’s positive results from the Phase III REGENCY study of Gazyva® (Obinutuzumab) for people with active lupus nephritis ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

Black History Month is a time to honor the strength, resilience, and contributions of the Black community. This year, we’re focusing on the theme “Your Voice, Your Power” to highlight the importance ...

In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene Therapeutics’ ALLO-329, an investigational allogenic CAR-T cell therapy. Researchers ...